Table of Contents

2019-2024 Global Levonorgestrel Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Levonorgestrel Consumption 2014-2024
  • 2.1.2 Levonorgestrel Consumption CAGR by Region
• 2.2 Levonorgestrel Segment by Type
  • 2.2.1 Levonorgestrel Table
  • 2.2.2 Mixture Products
  • 2.2.3 Hormone-releasing IUD
• 2.3 Levonorgestrel Consumption by Type
  • 2.3.1 Global Levonorgestrel Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Levonorgestrel Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Levonorgestrel Sale Price by Type (2014-2019)
• 2.4 Levonorgestrel Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug Store
  • 2.4.3 Online Sale
• 2.5 Levonorgestrel Consumption by Application
  • 2.5.1 Global Levonorgestrel Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Levonorgestrel Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Levonorgestrel Sale Price by Application (2014-2019)

3 Global Levonorgestrel by Players

• 3.1 Global Levonorgestrel Sales Market Share by Players
  • 3.1.1 Global Levonorgestrel Sales by Players (2017-2019)
  • 3.1.2 Global Levonorgestrel Sales Market Share by Players (2017-2019)
• 3.2 Global Levonorgestrel Revenue Market Share by Players
  • 3.2.1 Global Levonorgestrel Revenue by Players (2017-2019)
  • 3.2.2 Global Levonorgestrel Revenue Market Share by Players (2017-2019)
• 3.3 Global Levonorgestrel Sale Price by Players
• 3.4 Global Levonorgestrel Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Levonorgestrel Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Levonorgestrel Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Levonorgestrel by Regions

• 4.1 Levonorgestrel by Regions
  • 4.1.1 Global Levonorgestrel Consumption by Regions
  • 4.1.2 Global Levonorgestrel Value by Regions
• 4.2 Americas Levonorgestrel Consumption Growth
• 4.3 APAC Levonorgestrel Consumption Growth
• 4.4 Europe Levonorgestrel Consumption Growth
• 4.5 Middle East & Africa Levonorgestrel Consumption Growth

5 Americas

• 5.1 Americas Levonorgestrel Consumption by Countries
  • 5.1.1 Americas Levonorgestrel Consumption by Countries (2014-2019)
  • 5.1.2 Americas Levonorgestrel Value by Countries (2014-2019)
• 5.2 Americas Levonorgestrel Consumption by Type
• 5.3 Americas Levonorgestrel Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Levonorgestrel Consumption by Countries
  • 6.1.1 APAC Levonorgestrel Consumption by Countries (2014-2019)
  • 6.1.2 APAC Levonorgestrel Value by Countries (2014-2019)
• 6.2 APAC Levonorgestrel Consumption by Type
• 6.3 APAC Levonorgestrel Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Levonorgestrel by Countries
  • 7.1.1 Europe Levonorgestrel Consumption by Countries (2014-2019)
  • 7.1.2 Europe Levonorgestrel Value by Countries (2014-2019)
• 7.2 Europe Levonorgestrel Consumption by Type
• 7.3 Europe Levonorgestrel Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Levonorgestrel by Countries
  • 8.1.1 Middle East & Africa Levonorgestrel Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Levonorgestrel Value by Countries (2014-2019)
• 8.2 Middle East & Africa Levonorgestrel Consumption by Type
• 8.3 Middle East & Africa Levonorgestrel Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Levonorgestrel Distributors
• 10.3 Levonorgestrel Customer

11 Global Levonorgestrel Market Forecast

• 11.1 Global Levonorgestrel Consumption Forecast (2019-2024)
• 11.2 Global Levonorgestrel Forecast by Regions
  • 11.2.1 Global Levonorgestrel Forecast by Regions (2019-2024)
  • 11.2.2 Global Levonorgestrel Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Levonorgestrel Forecast by Type
• 11.8 Global Levonorgestrel Forecast by Application

12 Key Players Analysis

• 12.1 Bayer
  • 12.1.1 Company Details
  • 12.1.2 Levonorgestrel Product Offered
  • 12.1.3 Bayer Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer News
• 12.2 Paladin Labs
  • 12.2.1 Company Details
  • 12.2.2 Levonorgestrel Product Offered
  • 12.2.3 Paladin Labs Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Paladin Labs News
• 12.3 Foundation Consumer Healthcare
  • 12.3.1 Company Details
  • 12.3.2 Levonorgestrel Product Offered
  • 12.3.3 Foundation Consumer Healthcare Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Foundation Consumer Healthcare News
• 12.4 Theramex (Teva)
  • 12.4.1 Company Details
  • 12.4.2 Levonorgestrel Product Offered
  • 12.4.3 Theramex (Teva) Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Theramex (Teva) News
• 12.5 Pfizer
  • 12.5.1 Company Details
  • 12.5.2 Levonorgestrel Product Offered
  • 12.5.3 Pfizer Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Pfizer News
• 12.6 Apotex
  • 12.6.1 Company Details
  • 12.6.2 Levonorgestrel Product Offered
  • 12.6.3 Apotex Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Apotex News
• 12.7 HRA Pharma
  • 12.7.1 Company Details
  • 12.7.2 Levonorgestrel Product Offered
  • 12.7.3 HRA Pharma Levonorgestrel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 HRA Pharma News

...

13 Research Findings and Conclusion

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Levonorgestrel is widely sales through Hospital, Drug Store and Online Sale. The most proportion of Levonorgestrel is sales through Drug Store, and the proportion is about 73%.

According to this study, over the next five years the Levonorgestrel market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Levonorgestrel business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel market by product type, application, key manufacturers and key regions and countries.

This study considers the Levonorgestrel value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
Online Sale

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Levonorgestrel consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Levonorgestrel market by identifying its various subsegments.
Focuses on the key global Levonorgestrel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Levonorgestrel with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Levonorgestrel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.